People Briefs: FDA Turnover; Appointments At Boston Scientific, Dysis Medical
This article was originally published in The Gray Sheet
Executive Summary
FDA Chief Scientist Jesse Goodman leaves agency. New FDA deputy commissioner for global regulatory operations and policy appointed. Boston Scientific names new chief medical officer. More people briefs.